Technological University Dublin

ARROW@TU Dublin
Articles

DIT Biophotonics and Imaging

2014-03-29

Improved Protocols for Vibrational Spectroscopic Analysis of
Body Fluids
Franck Bonnier
Technological University Dublin, Franck.Bonnier@tudublin.ie

François Petitjean
Matthew Baker
University of Central Lancashire

See next page for additional authors

Follow this and additional works at: https://arrow.tudublin.ie/biophonart
Part of the Diagnosis Commons, and the Physics Commons

Recommended Citation
Bonnier, F. et al (2014) Improved Protocols for Vibrational spectroscopic analysis of body fluids, Journal
of Biophotonics, 7, pp.167-179. DOI: 10.1002/jbio.201300130

This Article is brought to you for free and open access by
the DIT Biophotonics and Imaging at ARROW@TU Dublin.
It has been accepted for inclusion in Articles by an
authorized administrator of ARROW@TU Dublin. For more
information, please contact arrow.admin@tudublin.ie,
aisling.coyne@tudublin.ie.
This work is licensed under a Creative Commons
Attribution-Noncommercial-Share Alike 4.0 License
Funder: SFI

Authors
Franck Bonnier, François Petitjean, Matthew Baker, and Hugh Byrne

This article is available at ARROW@TU Dublin: https://arrow.tudublin.ie/biophonart/11

Improved Protocols for Vibrational spectroscopic analysis of body fluids
Franck Bonnier1, François Petitjean2, Matthew J. Baker3, Hugh J. Byrne1

1. Focas Research Institute, Dublin Institute of Technology (DIT), Camden Row,
Dublin 8, Ireland
2. Haute Ecole Léonard de Vinci, Institut Paul Lambin, Brussels, Belgium
3. Centre for Materials Science, Division of Chemistry, University of Central
Lancashire (UCLan), Preston PR1 2HE, UK

*Corresponding Author: Franck Bonnier,
Focas Research Institute, Dublin Institute of Technology,
Kevin Street, Dublin 8, Ireland.
E mail address: fbonnier@dit.ie
Ph: +353 1 4027917
Fax: +353 1 4027904

Abstract

The applications of vibrational spectroscopy to the examination of human blood
serum are explored. Although FTIR spectra can be recorded in aqueous solutions at
(gelatin) concentrations as low as 100mg/L, the high-wavenumber region remains
obscured by water absorption. Using Raman spectroscopy, high quality spectra of
gelatine solutions as low as 10mg/L can be achieved, also covering the highwavenumber regions. In human serum, spectral profiles are weak and partially
obscured by water features. Dried deposits are shown to be physically and chemically
inhomogeneous resulting in reduced measurement reproducibility. Concentration of
the serum using commercially available centrifugal filter devices results in an
improvement in the spectral intensity and quality. Additionally, in Raman
spectroscopy, reduced background and significantly enhanced signal collection is
achievable by measurement in an inverted geometry. The improved protocols for
spectroscopic measurement of human serum are applicable to a range of bodily fluids
and should accelerate potential clinical applications.

Keywords: Infrared spectroscopy, Raman spectroscopy, bodily fluids, human serum,
centrifugal filtration

1. Introduction
Vibrational spectroscopic techniques, both Raman and Infrared absorption
spectroscopy, have significant potential in the field of biomedical analysis, as they can
give molecularly specific biochemical information without the use of extrinsic labels
and without being invasive or destructive to the system studied. They are routine
techniques for fingerprinting and identifying chemicals and act as standard methods in
analytical chemistry and pharmacy[1]. Both techniques being truly label-free, since the
inherent vibrational signature of the biochemistry of the cell or tissue is being
observed[2], their potential for diagnostic applications has been well investigated and
demonstrated, notably in dermal applications
sites, including cervix
[17]

, prostate

[18]

[7, 8]

, skin[9-11], lung

, nasopharynx

[19]

, larynx

[3-6]

[12, 13]

[20]

but also for many other anatomical

, brain

, oral

[21]

[14]

, oesophagus

, breast

[22, 23]

[15, 16]

and liver

, colon

[24]

. The

detailed information of the molecular structure and composition of the tissue provided
by Raman and Fourier Transform Infrared absorption (FTIR) spectroscopy ultimately
promises an analysis of disease origin and progression. Thus, they offer additional
information, potentially valuable for diagnosis, that is not provided by, for example,
X-ray or MRI techniques[22]. However, although often referred to as complementary
techniques, Raman and FTIR spectroscopy are based on very different fundamental
physical

phenomena,

and

thus

present

different

relative

advantages

disadvantages, and indeed technical challenges to their clinical implementation

and
[25, 26]

.

For example, Raman microspectroscopy presents several advantages for the study of
live cells, combining molecular analysis with optical imaging. The specific
information contained in the Raman spectra can be related to changes to the
physiology as a result of external stimuli[27-30]. The spatial resolution is of the order of
0.5-2 m, providing access to the subcellular organisation of the cells at a molecular

level[31-35]. In the case of FTIR spectroscopy, the spatial resolution is limited to some
5-10 m in free space applications, although this can be reduced to 1-2 m using high
numerical aperture microscopic objectives, as in the case of Attenuated Total
Reflection (ATR) FTIR microspectroscopy. The water contribution to the data
collected remains a critical difference between the techniques. Whereas dry samples
are often required for FTIR analysis of tissue sections, Raman microspectroscopy is
perfectly compatible with water immersion measurement which enhances the signal to
background ratio and the collection of higher quality data

[36, 37]

. The weak

contribution from water offers the possibility to study cells in an aqueous environment
and thus to keep them alive for the duration of the measurement[2, 31, 38], whereas the
strong absorption from water means that such measurements in infrared can only be
performed with high brightness sources such as synchrotrons [39].
Although widely applied to cell and tissue analysis, new challenges are presented by
applications of vibrational spectroscopic techniques to bodily fluids, for diagnosis and
health monitoring, which would present a less invasive approach than performing
biopsies of organs for example during cancer screening[40]. In this context, blood
serum presents a promising candidate for the application of vibrational spectroscopy.
The analysis of the proteins present in the blood stream can potentially deliver crucial
information on patient health and indicate the presence of numerous pathologies

[41]

.

Blood serum contains >20,000 different proteins ranging from 50 g.L-1 (serum
albumin)

, to less than 1 ng.L−1 (troponin)

[42, 43]

[44]

, with an overall protein

concentration of ~1 mM. Although other components such as lipids (lipoproteins) can
also be found, protein sensing remains the main challenge for diagnostic purposes.
The low molecular weight fraction of the serum, referring to by the term “peptidome”,
is of particular interest for the potentially rich cancer-specific diagnostic information

it contains. Bound to high-abundance proteins such as albumin, it represents a
fingerprint of the molecular events taking place within different organs or tissues
related to the presence of cancers but also modification to their close microenvironment [45, 46]. Therefore, the analysis of protein imbalances in the serum can be
[47-50]

directly related to, and indicative of, disease states

. Due to the complex

composition of the serum, different tools can be employed for the detection of
proteins levels, such as electrophoresis or 2D-SDS-PAGE. The use of monoclonal
antibodies can also be useful for detection of small quantities of proteins. Recently,
fluorescence based sensing methods using nanoparticles have been developed for
more sensitive and cost effective evaluation of proteins levels in the serum [51, 52].
The potential of FTIR and Raman spectroscopy has been widely investigated for
diagnostic purposes for cell and tissue analysis and the feasibility to use them for
serum sensing has been suggested and applied to a wide range of body fluids
ranging from serum

[54-57]

, tears

[58]

urine or saliva

[53]

[59-61]

. In both Infrared and Raman

spectroscopic studies, to date the analysis has predominantly been performed on air
dried drops of serum deposited on spectroscopically neutral substrates such as CaF2[62,
63]
.

The main reasons is the relatively low concentration of analytes in the serum,

leading to poor signal to noise ratios from liquid body fluids (Raman spectroscopy) or
the strong contribution of water in the spectra collected (Infrared spectroscopy).
Although commonly used, the question of sample homogeneity and measurement
reproducibility is of concern. Already highlighted in the literature in the case of serum
and tears analysis

[58, 63, 64]

, the deposition of a drop following by air drying (also

referred as drop coating) doesn’t necessarily generate a homogenous film of proteins
on the substrate. Therefore, the repeatability and accuracy of such studies remains
limited, often leading to statistically non relevant results. As drying of the liquid

samples is accepted as a routine procedure, many efforts have been devoted to the
development of robust and complex multivariate analysis methods in order to
statistically discriminate the datasets

[65, 66]

, rather than improving and adapting the

protocols used for sample preparation.
There is a dearth of vibrational spectroscopic studies using liquid samples for in the
literature

[62, 67-69]

and limitations due to the presence of water are often quoted in

recently published materials

[70]

. Therefore, in the present study, different approaches

will be described and proposed as alternatives in order to demonstrate and highlight
the feasibility to record high quality data without the requirement for water free
samples. The application of vibrational spectroscopy to human serum has been taken
as an example, although they are ultimately adaptable to any of the human body
fluids. Concentration dependent measurements of solutions of pure biochemical
compounds are used to explore the spectral ranges available to both FTIR and Raman
spectroscopy as well as the relative sensitivities and detection limits. Sample
concentration by centrifugal filtration significantly improves the spectral quality in
both spectral modalities, but further improvements can be achieved in Raman
spectroscopy by tuning the acquisition protocols, and notably, the spectral integrity in
the higher wavenumber region is retained.

2. Materials and Methods
2.1 Sample preparation

L-proline (Sigma Aldrich, Ireland P4655) and glycine (Sigma Aldrich, Ireland
G8898) were first analyzed in the powder form. Additional samples were prepared by
dilution in distilled water ranging from 25 mg/mL up to 300 mg/mL. Gelatin (BDH,

Ireland, 44045) was also analysed in both the powder form and after dilution in
distilled water at concentrations from 10 mg/mL - 400 mg/mL. Solutions were either
analyzed in the liquid form or after deposition on a CaF2 window, after which they
were air dried.
Sterile filtered human serum from normal mixed pool (off the clot) was purchased
from TCS Biosciences (Ireland). Samples were prepared either by deposition of 20 µL
of the serum on a CaF2 window (Crystran Limited, UK) followed by air drying or
filtration of 0.5 mL of the serum using Amicon Ultra-0.5ml centrifugal filter devices
(Merck, Germany). In the case of centrifugally filtered devices, the 3K device was
employed, and 0.5 mL of the serum was placed in the device and centrifuged at
14,000 x g for 30 mins. The filtrate is mostly composed of water and molecules
smaller than 3K molecular weight, while the remainder of the serum (concentrate) is
retained in the filter device. The filter device is then placed upside down in a new
Eppendorf and spun down at 1 000g for 2 mins. The resultant is a concentration by a
factor of 10 for the remaining serum, with a resultant concentrate volume of ~50 μL.
2.2 FTIR Instrumentation
IR absorption measurements were carried out using a Perkin Elmer Spotlight 400N
FTIR imaging system. For comparison, the data have been collected using both the
transmission mode and ATR mode.

2.2.1 Data collection using the transmission mode
The system is equipped with an AutoImage microscope system operating with a x 40
Cassegrain objective, and can operate in transmission or reflection mode. FTIR data
acquired in transmission mode were collected over the nominal free-scanning spectral
range with an interferometer speed of 1.0 cm/s using a liquid nitrogen cooled mercury

cadmium telluride (MCT-A) line detector. Spectral measurements were acquired with
a pixel size of 25 μm x 25 μm at a spectral resolution of 4 cm-1. Background
measurements were acquired on a blank substrate with 120 scans per pixel whereas 8
scans per pixel were recorded from the sample. 20 µL of the prepared solution was
deposited on a CaF2 window and air dried before recording.
2.2.2 Data collection using the UATR
ATR spectra were recorded with the Perkin Elmer Spotlight 400N Universal
Attenuated Total Reflectance (UATR) accessory of the spectrometer. In ATR mode,
spectral data were the result of 4 scans, with a spectral resolution of 4 cm-1. Either 1
mg of the powder or 20 µl of the solution for the different compounds tested was
deposited on the crystal for recording. Prior to recording, a background spectrum was
recorded and automatically subtracted by the software.
2.3 Raman spectroscopic measurements
A Horiba Jobin-Yvon LabRAM HR800 spectrometer was used throughout this work.
The spectrometer can be coupled to either an Olympus BX41 upright or an Olympus
IX71 inverted microscope. For the measurements, a x60 water immersion objective
(LUMPlanF1, Olympus) was employed, providing a spatial resolution of ~1-2m at
the sample with a laser intensity of between 35 – 40 mW for each microscope. The
confocal hole was set at 100m for all measurements, the specified setting for
confocal operation. The 785 nm laser line was used in this work, and the system was
spectrally calibrated to the 520.7 cm-1 spectral line of silicon.
In the following experiments, the 300 lines/mm grating was used, providing a spectral
dispersion of approximately 1.5 cm-1 per pixel with the 785 nm laser line. The
backscattered Raman signal was integrated for 2 x 30 seconds over the spectral range

from 400 to 1800 cm-1. The detector used was a 16-bit dynamic range Peltier cooled
CCD detector.

3. Results and discussion
3.1 Infrared spectroscopy of pure chemicals

The feasibility of recording infrared spectra from solutions of pure biochemical
compounds using FTIR spectroscopy has been evaluated using gelatin (figure 1A),
proline and glycine (data not shown) diluted in water at different concentrations.
Figure 1A (red spectrum) shows a spectrum recorded from the gelatin powder using
the UATR accessory in the range from 2400-4000 cm-1. The spectrum of gelatin is
rich in this region, the main features being located at 3281 cm-1, 3074 cm-1, 2938 cm-1
and 2877 cm-1 (figure 1A: Red spectrum). In aqueous solution, however, these
features are swamped by the water contributions (Figure 1A Black) and even at
concentrations of 400mg/mL, which was close to the saturation point of solubility of
gelatin in water, no features of the gelatin can be clearly identified (figure 1A Blue).
In the fingerprint region, however, the contributions of water are significantly less,
and the features of the gelatin are readily observable. Figure 1B displays spectra
obtained from gelatin solutions ranging from 100 mg/mL up to 400 mg/mL, along
with that of pure water. The spectral profiles evolve according to the concentration,
especially in the fingerprint region where the specific peaks of the gelatin
systematically increase, the best visualization of the spectral profile being reached for
the 400 mg/mL solution.
In this spectral range, the water exhibits only a single feature at 1638 cm-1,
overlapping with the amide I band, characteristic of protein rich samples, and also

partially overlapping with the amide II band region (1580-1490 cm-1). However, when
increasing the concentration of the solution, the different features of the gelatin can be
seen to systematically evolve. The amide I band appears gradually shifted from 1638
cm-1 to 1630 cm-1 and the amide II band at 1551 cm-1 becomes better defined.
Different features can also be seen in the spectral window 1500-1000 cm-1, the main
peaks being localised at 1453 cm-1 1407 cm-1, 1336 cm-1, 1284 cm-1, 1246 cm-1, 1202
cm-1, 1163 cm-1, 1081 cm-1 and 1034 cm-1. The evolution of the features as a function
of concentration fits well with a Lambert-Beer like response, as shown in Figure 2 for
the case of the integrated areas of the Amide I and Amide II bands. Error margins for
the measurements are those of the spectral measurement and the concentration
determination, both of the order ±5%. The solid lines show a linear regression fit to
the absorbance data. At the lowest concentration measured (100) mg/mL, water
accounts for ~ 85% and ~71% of the absorption in the amide I and amide II regions
respectively (dotted horizontal lines). Notably, extrapolation of the regression to the
intercept with the water integrated water absorbance for the respective regions
indicates a sensitivity of <10mg/mL.

3.2 Infrared spectroscopy of Human serum

A commonly employed approach to analyzing the composition of biological fluids
using FTIR is to deposit a drop of the solution on a suitable substrate such as CaF2
and air dry the sample before collection of spectra in transmission mode

[62, 63, 70, 71]

.

The process concentrates the analytes from the solution, potentially allowing better
signal to noise, but results in a physically and chemically inhomogeneous sample and,
as demonstrated in the previous section, the spectra of the constituent molecular
components can be significantly altered in the condensed form. Figure 3 (top)

presents an infrared transmission image collected from a 20 μL drop of human serum
after air drying on a CaF2 window. Three examples of spectra taken from different
regions of the drop from the inner to the outer region are also displayed. After drying,
the serum forms a highly concentrated thin film on the substrate, leading to the
saturation in the absorbance read. The maximum absorbance is observed in the center
of the deposit. Thus, in order to record infrared spectra from dry serum, a dilution has
to be applied. Figure 3 (bottom) presents the infrared image obtained from a dried
deposit after dilution of the serum by a factor of 15 using distilled water. After
dilution, a ring of highly concentrated proteins is located on the outer part of the
deposit. As the central area gives little or no absorbance, it is not usable for chemical
characterization. The main limiting aspect of depositing and air drying the serum
remains the inhomogeneity of the resulting deposit. The different serum proteins have
differing affinities for adsorption onto the substrate surface which results in varying
rates of deposition and therefore physical and chemical inhomogeneity in the
deposited layer – the so-called Vroman effect.[72] The spectra A, B and C in figure 3
(bottom) illustrate the variation in the spectra collected from the inner, middle and the
outer part of the ring. For better visualization, the region 1500-1000 cm-1 has been
plotted. The dotted lines indicate shifts in the features, while the arrows highlight a
change in the band intensity ratios depending of the location of the spectra. Thus, the
use of serum deposited and dried on a substrate will generate variations in the spectral
features due to physical and chemical inhomogeneities and, given the uncertainties in
the results, is not a satisfactory protocol for diagnostic applications.
However, as demonstrated in section 3.1, the recording of Infrared spectra from
aqueous solutions, at least in the fingerprint region, is possible and is thus the best
candidate for the study of human serum. As highlighted in figure 1, however, the use

of highly concentrated solutions is required for infrared spectroscopy in order to
reduce the water/protein ratio in the spectra collected, but the fully condensed solid
phase results in physically and chemically inhomogeneous samples. Therefore a
method of controlled systematic concentration of the serum samples is desirable.
Commercially available, Amicon ultra-0.5 centrifugal filter devices (Merk) provide,
as described by the manufacturer, “a fast ultrafiltration, with the capability for high
concentration factors and easy concentrate recovery from the dilute and complex
matrices”. The centrifugal filter devices can be purchased for different cutoffs
(Nominal Molecular Weight Limit ranging from 100K to 3K). In the present study,
the feasibility to analyse the whole serum was explored, and thus the 3K (3000
NMWL) was employed, which means any molecule with a molecular weight higher
than 3K will be retained in the devices and present in the final concentrate used for
spectroscopic analysis. 0.5 mL of the serum was placed in the device and centrifuged
at 14 000 x g for 30 mins, giving a concentrating factor of 10 with a resultant
concentrate volume of ~50 μL.
After recovery, 20 μL of the final concentrate was deposited on the UATR accessory
and an infrared spectrum was collected. Figure 4II compares the infrared spectra
recorded from human serum using the UATR accessory, in its pristine liquid state
(figure 4IIB) and after concentration using centrifugal devices (figure 4IIA). In the
pristine liquid state, the signal obtained remains dominated by the water band and
only small protein related features are observable. After centrifugal filtration,
however, strong features of the serum begin to dominate the spectrum. The major
bands are visible at 1637 cm-1 (Amide I band), 1445 cm-1, 1452 cm-1, 1402 cm-1, 1312
cm-1, 1244 cm-1, 1170 cm-1 and 1080 cm-1, consistent with observations made on air
dried serum, despite the lack of accuracy due to the in-homogeneity in the data

collected after air drying. An increase of the absorbance of all features (above the
level of the water absorbance) by a factor of approximately 5 in the finger print region
can be observed. Therefore, the use of centrifugal filter devices can bring new
expectations regarding the application of Infrared spectroscopy for the analysis of
human serum with the possibility to strongly reduce the water contribution and thus
better visualize the presence of the different features related to the complex
composition of the serum. However, even at these concentration factors, the spectral
range 2800-3700 cm-1 remains dominated by the water features, as shown in figure 4I.
The serum recorded after ultrafiltration displays only weak features between 30002600 cm-1 (figure 4I red spectrum) and is still dominated by the strong absorbance of
the remaining water in the sample (figure 4I spectrum black and blue). Therefore, the
main limitation to FTIR spectroscopic analysis of bodily fluids remains the restriction
in the accessible spectral range as, although the finger print region remains the most
informative regarding the molecular composition of the samples, the high
wavenumber spectral range could bring relevant information for more specific
chemical characterization.

3.3 Raman microspectroscopy of pure chemicals

The relatively weaker signal from water in Raman spectroscopy presents many
advantages compared to infrared spectroscopy, especially for the analysis of live cells,
which is facilitated by the use of a water immersion objective to be able to collect
Raman spectra directly from cells maintained alive in a saline solution or medium

[31]

.

However, although the water contribution is weak, it can still contribute over an
important part of the final spectrum collected. As seen for Infrared spectroscopy, the
Raman spectroscopic technique has a limit of detection for molecules diluted in an

aqueous solution. As an example, the recent work conducted on 3D collagen gels
demonstrated that the fibrous protein forming the gel upon which to grow the cells
was still too low in concentration to be detected with Raman spectroscopy[73]. The
main question is to evaluate the capacity of Raman spectroscopy to record spectra
from human serum.
Figure 5I displays examples of spectra recorded from gelatin solutions ranging from
200 mg/mL to 10 mg/mL (figure 5I B-E) compared to a spectrum of gelatin recorded
from the lyophilized form before preparation of the solution (figure 5IF) and a
spectrum of de-ionised water (figure 5IA).

As seen for the FTIR analysis, the

intensities of the Raman peaks increase systematically with concentration, although
notably the Raman spectra are strikingly richer in spectroscopic detail. The spectrum
of figure 5IE is very similar to the one obtained from the gelatin powder (figure 5IF),
while the gelatin features are significantly diminished in the spectrum collected from
the solution at 10 mg/mL which displays a stronger contribution of the water (figure
5IB).
In Raman spectroscopy, the finger print region between 400-1800 cm-1 is strongly
influenced by the presence of a slowly varying, broad background generating an
offset of the spectra but also influencing the signal to background ratio and thus the
relative band intensity. Thus, the exact evaluation of the water contribution to the
final spectra in the region of the amide I band remains difficult. However, the high
wavenumber region between 2800-3700 cm-1 is not influenced as strongly by this
background and can provide a more precise estimation of the water contribution
(figure 5II), which is notably significantly less intense than that observed in FTIR
(figure 1). The spectral range 2845-3040 cm-1 exhibits features related to the presence
of proteins and lipids in the samples (in the case of gelatin, only protein related) and

notably, whereas they are swamped by the water absorptions at 400mg/mL in FTIR,
they are clearly discernible in the Raman spectra of solutions as dilute as 25mg/mL
(figure 5II red spectrum).

As in the case of FTIR spectra of solutions, a linear dependence of the integrated
bands are observed, as shown in Figure 6 for the case of the high wavenumber region
(2820 cm-1 – 3020 cm-1), the amide I band (1560 cm-1 -1715 cm-1) and the region
between 1215 cm-1 -1290 cm-1. Again, error margins for the measurements are those
of the spectral measurement and the concentration determination, both of the order
±5%. The solid lines show a linear regression fit to the absorbance data. Notably, in
comparison to the FTIR data, at a concentration of 100mg/mL, the contributions of
water to the respective regions are reduced to 44%, 64% and 7%.

Whereas FTIR absorption spectroscopy measures the light absorbed by the sample,
Raman spectroscopy measures the light (inelastically) scattered by the sample, and
thus significant improvements in signal quality can be achieved by improved signal
acquisition protocols. The Raman signal intensity is directly correlated with the
amount of backscattered light captured by the objective and redirected to the detector
over time. Thus, increasing the acquisition time will induce an increase in the overall
spectral intensity but is also accompanied by an improved signal to noise (S/N) ratio.
In order to illustrate this effect, the solution of gelatin at 10 mg/ml has been recorded
using an acquisition time of 150s. Using a spectrum of distilled water as a reference
and recorded under the same conditions, it is possible to remove the background
present in the spectrum by subtraction to better visualize the gelatin features (figure
5IG). Increased source power can also be used to increase the S/N ratio, and therefore,
Raman microspectroscopy can potentially detect chemicals present in a solution at

much lower concentrations compared to FTIR. The use of a more powerful laser
source would effectively further reduce the required acquisition time, allowing rapid
collection of data from solutions with high signal to noise ratio.

3.4 Raman microspectroscopy of Human serum

3.4.1 Instrumental set up
Figure 7IC shows a Raman spectrum of human serum recorded in the upright
geometry using a x60 objective. Protein like features can be clearly seen above the
water background, although in comparison to, for example, the gelatin solution
spectrum of figure 5I, the spectral features are relatively poorly defined.

When performing measurements with Raman spectroscopy, different objectives can
be employed with different characteristics related to the magnification desired. In
order to achieve the highest spatial resolution, the X100 objective can be employed on
dry cells or tissue sections. As presented in figure 7II, the sample is usually placed on
top of a suitable substrate such as CaF2, allowing to focus the laser on its surface.
Using a MplanN objective with a numerical aperture (NA) of 0.9, the working
distance is about 0.21 mm. However, when working in immersion using a x60 or
x100 water immersion objective with a NA of 1, the working distance is increased to
about 2 mm. Although the recording of Raman spectra from the human serum stock
solution can be performed directly by immersing the lens in the solution using the
upright microscope (as performed in section 3.3 for gelatin solutions), such an
approach can be limited when collecting data from smaller volumes, as in the case of
concentrated serum. When deposited on a CaF2 window, the focal point of the laser is
outside the drop, as illustrated schematically in figure 7IIB. In order to better analyse

the serum, the distance between the sample and the objective has to be increased. This
is achievable by using an inverted microscope (figure 7IIC). Coupling a thin CaF2
(thickness 0.15 mm) to the water immersion objective, the collection of Raman
spectra from the serum can be performed. A drop of water is used to reduce the
variation in the refractive indexes between the objective, substrate and serum.
Notably, as they are outside the focus of the beam, the water drop does not contribute
to the spectra collected and only an insignificantly weak signal form the CaF2 can be
seen.
Figure 7IB shows a Raman spectrum of human serum stock solution measured using
such an inverted geometry. In comparison to the same measurement performed in the
inverted geometry, the spectrum is significantly enhanced and the spectral features are
considerably better defined.

3.4.2 Impact of centrifugal filtration

Figure 7IA presents a spectrum of human serum after filtration using an Amicon
ultra-0.5 centrifugal filter device (Merk). As in the case of the FTIR, significant
improvements in the sample signal can be achieved by increasing the analyte
concentration in the solution using centrifugal filtration, as can be seen by comparison
with the spectrum of non-unfiltered serum measured under identical conditions (figure
7IB). The spectrum of figure 7IA exhibits dramatic improvements in the spectral
intensities and quality. Moreover, the difference in intensity between the pure
deionised water and the spectrum collected from the concentrated serum clearly
indicates that minimal contribution from the water occurs with such samples (data not
shown).

The improvements of the Raman spectrum achievable by filtration are equally evident
in the high number region, as shown in figure 7III. Spectrum A of 7III has been
collected from distilled water as a reference while the spectrum B has been recorded
from the serum. The intensity of the band of the water located at 3210 cm -1 is
significantly decreased with the apparition of 2 peaks at 2930 cm-1 and 2875 cm-1.
After centrifugal filtration, the band of the water is strongly reduced to almost the
same intensity of the background, whereas the peaks at 2930 cm-1 and 2875 cm-1 have
significantly stronger intensities and an additional peak is clearly discernible at 3060
cm-1 (figure 7IIIC).
4. Discussion

The analysis of human serum but also body fluids can be performed using the
immersion lens. As for the analysis of live cells, the water immersion objective can be
directly dipped into the analyte solution, minimising the intensity loss in the spectra
collected by optimizing the optical coupling between the lens and the liquid sample.
For measurement of centrifugally filtered serum, the recovery volume is the main
limiting factor in such approach. The working distance of the water immersion lens
being about 2 mm, the effective thickness of the serum drop after deposition on the
CaF2 substrate was found to be too low and also not consistent. The interaction of the
concentrate serum with the surface of the substrate varies between samples thus,
although the concentrate recovery volume remains quite consistent, the drop size and
shape can vary quite considerably.
The use of the inverted geometry improves the reproducibility of the measurements of
concentrated serum, which will allow standardization. The size and shape of the drop
have little impact on the data collected. The laser being focused on the interface

between the deposited liquid sample and the CaF2 substrate, as little as 20 µL of the
concentrated serum can be used for the analysis. Although this work was a proof of
concept based on Ultra-0.5 centrifugal filter devices (Merck, Germany) with a
Nominal Molecular Weight Limit (NMWL) of 3K, it is important to point out that
many different cut off point are available on the market to specifically separate
proteins with high molecular weight. For example, as specified by the manufacturer,
centrifugal devices with NMWL of 10K, 30K, 50K or 100K have higher
concentrating capacities but this is also associated with smaller recovery volume in
the order of 20 µL. Such small volumes cannot easily be recorded using the upright
set up can be much more readily analysed using an inverted microscope.
Moreover, although in the present study, the human serum is healthy and free of any
infection, the ultimate aim is to perform analysis of serum taken from patients for the
identification of specific biomarkers for diagnostic purposes. Thus, it is important to
design a set up compatible with health and safety legislation. Direct contact between
the lens and the serum itself would require appropriate cleaning between
measurements. Inverted measurement through a substrate reduces the cleaning and
sterilization requirements without worrying about damaging the immersion objective.
Human serum is composed of up to 10,000 proteins, although most are present at very
low relative abundances. Serum, derived from plasma with clotting factors removed,
contains 60–80 mg of protein/mL in addition to various small molecules including
salts, lipids, amino acids, and sugars[42]. The use of centrifugal filters raises the
question of alteration of the serum composition. The NMWL of the devices means
any molecules of less than 3000 g/mol will be wholly or partially removed from the
concentrate which remains in the filter, and are passed through as filtrate. For
example, Glucose, with a molecular mass of 180 g/mol should be effectively removed

by centrifugation. Recent studies suggest that low molecular weight (LMW) proteins
are particularly interesting for the use of serum for diagnostic applications

[74]

.

Notably, Hands et al[75] have recently demonstrated the use of centrifugal filtration of
serum samples for the diagnosis of gliomas using FTIR spectroscopy of the lower
molecular weight filtrate (<10kDa). Although the molecular weight of LMW proteins
remains close to the cutoff point of the centrifugal devices used in this work,
commercially available devices with lower NMWL can be purchased, retaining
molecules with LMW down to 2K. Moreover, although some LMW (low molecular
weight) proteins can be filtered out and lost in the process, the use of such filtering
devices offers the advantage of removal of undesirable substances from the serum,
such as salts and sugars which can potentially spectroscopically interfere with the
proteome analysis. As the principal objective of this work was the demonstration of
improved measurement protocols rather than in depth analysis of the serum proteome,
the 3K Amicon centrifugal devices have been considered suitable. However, for
future investigation, the use of lower NMWL devices should be investigated.
Rohleder et al.[62] have undertaken a comparison of FTIR and Raman spectroscopies
for the quantitative analysis of human serum, also in relation to other common clinical
enzymatic analysis techniques. Multivariate regression was employed to analyse the
glucose content in spiked patent samples and root mean square errors of prediction of
14.7 and 17.1 mg/dl for mid-infrared and Raman spectroscopy, respectively were
achieved. The study concluded that the accuracy of current clinical analytical methods
is substantially better than that of vibrational spectroscopies and that vibrationalspectroscopy based quantification appears to be limited to accuracies in the 0.1
mmol/L range, regardless of the particular choice of the spectroscopic technique.
Notably, in this study, samples for FTIR measurement were taken from dried samples

whereas those for Raman spectroscopy were taken from unfiltered unconcentrated
serum.
In the study presented here, it has been demonstrated that FTIR measurements of
biochemical species can be made in water solution. Although the high wavenumber
region is effectively unusable due to water absorption, clear absorption features are
visible in the fingerprint region of gelatin solutions as low as 100mg/mL. The average
molecular mass of gelatin is ~50kg/mol, and thus this corresponds to 2mmol/L. In the
case of human serum, concentration by a factor of ten by centrifugal filtration results
in a ten fold increase in absorbance of all features in the fingerprint region, although
the high wave number region remains obscured by water absorption, even at these
elevated concentrations. Critically, the ability to measure human serum in the solution
phase at higher concentrations should significantly reduce the measurement
predictability, identified by Rohleder et al.[62] as a lower limit on the prediction errors
in mid-infrared spectroscopy.
In Raman spectroscopy the interference of water in the spectral signatures of
biochemical species is less than for FTIR. In gelatin solutions, clear spectral features
are observable at concentrations as low as 10mg/mL, notably in both the fingerprint
and high wavenumber regions. Significant improvements in signal to noise are
achievable by prolonged acquisition times, and detailed, high quality spectra of
10mg/ml gelatin solutions are achievable after 6-7 minutes, indicating that Raman
spectroscopy holds significantly higher potential for applications to analysis of bodily
fluids.
In recent years, there has been increased interest in blood serum analysis using
Surface Enhanced Raman Spectroscopy (SERS), which can compensate for the low
Raman scattering efficiency, especially limiting in the case of liquid samples[76].

Reported studies applied to blood serum[77] for the detection of gastric
colorectal

[80]

, pancreatic[81] and naso-pharyngeal cancers

[82]

[78, 79]

,

highlight the interest

and potential of such approaches. However, the use of nano-particles or appropriate
metallic based substrates[83] is required, and while the approach is promising,
reproducibility in the data collected remains a challenge

[84]

. Moreover, the question

of selectivity and sensitivity are questionable, especially in presence of high
molecular weight proteins[85].
Therefore, the development of more suitable protocol for Raman microspectrsocopy
remains crucial for the analysis of body fluids leading to a better detection of the
Raman signatures in liquid samples. Thus, as presented in the present study, for the
case of human serum, sample concentration by a factor of 10 by centrifugal filtering
dramatically improves the spectral intensity and signal to noise without the
requirement of further signal enhancement with nano-particles. Although the standard
upright measurement geometry can be employed, reduced background is achievable
by measurement in an inverted geometry, using an immersion objective. Enhanced
signal intensities allow reduced acquisition times with the promise of high throughput
in routine screening applications. Ultimately, in clinical environment, such a
geometry has the advantage that it provides improved signal quality through
immersion, without the danger or inconvenience of contact of the objective with the
sample.

5. Conclusion
Although vibrational the spectroscopic techniques of infrared absorption and Raman
scattering have been widely explored for diagnostic applications in tissues ex vivo and
cellular analysis in vitro, their applications to bodily fluids has largely been limited

due to weak spectral signatures of the relevant analytes in pristine fluids, and the
physical and chemical inhomogeneities of solid deposits. Concentration dependent
measurements of pure biochemicals in aqueous solution demonstrates, however, that
both methodologies can be employed for sensitive quantitative measurements,
although the high wavenumber region the spectral features of the analytes are
obscured by those of water in the case of FTIR. In the case of human serum, both
FTIR and Raman spectroscopy give relatively weak signals, but the signal to
background ratios are considerably enhanced by the used of commercially available
devices ultra-0.5 centrifugal filter devices (Merck, Germany) which result in a
concentration of the analytes by a factor of ~10, and a consequent increase in the
spectral signatures. Although the high wavenumber region is still obscured by water
in the case of FTIR, the full spectral region is dominated by protein features in the
case of Raman spectroscopy. Collection efficiency for immersion Raman
spectroscopy can be further enhanced by the use of an inverted geometry. Using
centrifugal filtration devices to remove of low molecular weight proteins, enhances
signals and intrinsic spectral reproducibility. These improved spectral acquisition
protocols opens up the potential applications of real clinical applications for
spectroscopic analysis of bodily fluids.
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Figure legends

Figure 1: Example of spectra recorded using the UATR accessory of the Perkin Elmer
Spotlight 400N. A: high wavenumber region from water (black); gelatin at 400
mg/mL (blue) and gelatin powder (Red). B: finger print region from gelatin solutions
at a concentration of 100 mg/mL (blue), 200 mg/mL (red), 300 mg/mL (green) and
400 mg/mL (black). For comparison, a spectrum of distilled water has been added
(pink) No offset or correction has been applied.

Figure 2: A: Area under the Amide I band (1740-1580 cm-1) and B: Area under the
Amide II band (1580-1500 cm-1). The dotted lines are the respective integrated
intensities recorded from de-ionised water.

Figure 3: Top: Infrared transmission image collected from a 20 µl drop of human
serum after air drying with the corresponding spectra extracted from the labeled
regions A, B and C. Bottom: Infrared image collected for a 20 µl drop of human
serum diluted 1/15 after air drying. Spectra collected in the region A, B and C are also
presented. The spectra have been baseline corrected and vector normalised.

Figure 4: Infrared spectra recorded using the UATR accessory of the Perkin Elmer
Spotlight 400N. I: Black: infrared spectra from distilled water; Blue: Infrared spectra
from human serum; Red: Infrared spectra from human serum after centrifugal
filtration. II: A: Infrared spectrum from human serum after centrifugal filtration; B:
Infrared spectrum from human serum; C: infrared spectra from distilled water; No
offset or corrections have been applied to the spectra.

Figure 5 I: Spectra recorded using the 785 nm laser line. A: deionised water; B:
gelatin 10 mg/mL; C: gelatin 25 mg/mL, D: gelatin 100 mg/mL E: gelatin 200
mg/mL, F: Lyophilized gelatin and G: gelatin 10 mg/mL (2x150s – 60x water
immersion objective) after water subtraction (intensity x8 for comparison). Spectra
have been offset for clarity. II: Raman spectra recorded in the high wavenumber
region of gelatin solutions at a concentration of 200 mg/mL (pink), 100 mg/mL
(green), 25 mg/mL (red) and 10 mg/mL (blue). For comparison, a spectrum of
distilled water has been added (light blue) No offset or correction has been applied.

Figure 6: Area under the curve of the protein features in the high wavenumber region
(2820cm-1-3020cm-1), the amide I band, and the region between 1215 cm-1 -1290 cm-1
of gelatin solutions at a concentration of 200 mg/mL), 100 mg/mL, 25 mg/mL and 10
mg/mL. The dotted lines represent the integrated baseline contributions of pure water
in each frequency region.

Figure 7: Raman spectra recorded from human serum using Labram HR 800. I: Using
the inverted set up after centrifugal filtration; B: In the standard upright position using
a X60 immersion objective and C: Using the inverted microscope couple to the
immersion X60 objective. II: Examples of different settings used for the analysis of
human serum using Labram HR 800. A: in the standard upright position; B: In the
standard upright position using a X60 immersion objective and C: Using the inverted
microscope couple to the immersion X60 objective. III: A: Raman spectrum recorded
using the inverted set up from distilled water; B: Raman spectrum recorded from the
Human serum; C: Raman spectrum recorded from the Human serum after
ultrafiltration using the Amicon ultra-0.5 centrigugal filter devices 3K. No offset or
correction has been applied.

